USPTO BCP Blog Page TEST

Biotech/Chemical Partnership (BCP) meeting - Sept 16, 2020

Sep 29, 2020, 16:16 PM by Randy no-ams Sagara
BCP meetings are part of a long-standing partnership between the USPTO and its valued stakeholders that works to improve the quality the agency’s products and services.

BCP meetings are part of a long-standing partnership between the USPTO and its valued stakeholders that works to improve the quality the agency’s products and services. This meeting will cover:

  • Subject matter eligibility (35 U.S.C. §101) guidance update
  • Written description requirement for antibody
  • Expedited patent prosecution process
  • Major initiatives for patent application process
  • Sequence Searching
  1. TC1600_BCP_Agenda_09_2020
  2.  BCP-Patent Application Initiatives-Final
  3. BioChempartnership - Faster at the USPTORA
  4. CAMslidesWD_BCP_2020-09-17
  5. patent_blast
  6. PTO vaccines
  7. The Impact of § 101 on Pharmaceutical Patents
  8. USPTO-BCP-Antibody slides-Final
  9. USPTO-September 20200917